Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of aortic stenosis pilot trial
ISRCTN17365679Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Jun 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 2, randomised trial of sevelamer carbonate in aortic stenosis (AS), sponsored by Queen Mary University of London. Primary endpoint: Serum phosphate at 18 weeks. Started Jun 2017; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on ISRCTN17365679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17365679.